MMP11 and cancer: Nevertheless, pharmacological targeting of this protein using either antisense oligonucleotides, CRISP-Cas9 technology or monoclonal antibodies directed against MMP11 may prove efficient to impede rapid cancer progression by acting on multiple biological processes such as proliferation, apoptosis, metabolism, and organelle unfolded protein responses.